Hikal

L24200MH1988PTC048028 · ISIN INE475B01022 · 4 filings, FY 2022-23 to FY 2025-26 · consolidated basis

Reclaimed at end of life

Tonnes as filed. Totals combine re-used, recycled and safely disposed, because filers place comparable activity in different columns.

category_row_disappeared. FY 2025-26 omits other, filed in this company's other years. Absence is not a reported zero.

CategoryFY 2022-23FY 2023-24FY 2024-25FY 2025-26
Plastics including packaging not filednot filed208.550
E-waste not filednot filed2.350
Hazardous waste not filednot filed52,541.570
Other waste not filed4,366.446,088.11not filed
Total reclaimed 04,366.4458,840.580

Recycled or reused input material

Share of total material by value, per material line as the company named it. Each line carries its own denominator, so they are never summed or averaged.

Input material, as filedFY 2022-23FY 2023-24FY 2024-25FY 2025-26
Given the nature of our pharmaceutical and specialty chemical products, we do not use recycled or reused input materials in the manufacturing process. However, we are recovering more than 90% of process solvents and reusing them in the manufacturing process of pharmaceuticals and agrochemicals products. not filed0.0%0.0%not filed

NIC codes filed

Products and services accounting for 90 percent of turnover, latest filing.

CodeDescription as filedShare of turnover
20116 Manufacture of Basic Chemical Elements 40.00%
21001 Manufacture of Pharmaceutical Products 60.00%

Source filings

YearBasisTaxonomyTurnover as filed
FY 2022-23 Consolidated 2023-06-30 20,23,03,00,000
FY 2023-24 Consolidated 2024-04-30 17,68,65,70,000
FY 2024-25 Consolidated 2025-05-31 18,59,80,00,000
FY 2025-26 Consolidated 2026-02-28 17,12,60,00,000

Figures read from BRSR XBRL as filed. Nothing estimated or restated. How this works · Report an error